PULSION Medical Systems SE Stock

Equities

PUS

DE0005487904

Medical Equipment, Supplies & Distribution

End-of-day quote BOERSE MUENCHEN 06:00:00 2024-04-21 pm EDT 5-day change 1st Jan Change
17.5 EUR 0.00% Intraday chart for PULSION Medical Systems SE 0.00% +9.38%
Sales 2020 32.06M 34.22M Sales 2021 27.95M 29.84M Capitalization 160M 171M
Net income 2020 9M 9.61M Net income 2021 5M 5.34M EV / Sales 2020 5.61 x
Net cash position 2020 238 254.09 Net cash position 2021 142 151.6 EV / Sales 2021 5.72 x
P/E ratio 2020
19 x
P/E ratio 2021
27 x
Employees 66
Yield 2020 *
-
Yield 2021
-
Free-Float 99.94%
More Fundamentals * Assessed data
Dynamic Chart
PULSION Medical Systems SE Reports Earnings Results for the Full Year Ended December 31, 2022 CI
PULSION Medical Systems SE Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Pulsion Medical Systems Se Reports Earnings Results for the Full Year Ended December 31, 2020 CI
PULSION Medical Systems SE's Equity Buyback announced on May 16, 2012 has expired. CI
Tranche Update on PULSION Medical Systems SE's Equity Buyback Plan announced on May 16, 2012. CI
Maquet Spain, S.L., Sociedad Unipersonal acquired PULSION Medical Systems Iberica SL from PULSION Medical Systems SE. CI
Diagnostic Green GmbH acquired Perfusion Imaging business division from PULSION Medical Systems SE (DB:PUS). CI
Maquet And PULSION Announce Distribution Agreement For The PiCCO(R) And ProAQT(R) Hemodynamic Product Lines CI
PULSION Medical Systems SE Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Fiscal 2014 CI
PULSION Medical Systems SE Proposes Distribution of Dividend for the Fiscal Year 2013 CI
Tranche Update on PULSION Medical Systems SE (DB:PUS)'s Equity Buyback Plan announced on May 16, 2012. CI
Getinge AB (OM:GETI B) completed the acquisition of 78.55% stake of PULSION Medical Systems SE for approximately €110 million. CI
Getinge AB (OM:GETI B) made an offer to acquire PULSION Medical Systems SE for approximately €140 million. CI
Tranche Update on PULSION Medical Systems SE (DB:PUS)'s Equity Buyback Plan announced on May 16, 2012. CI
PULSION Medical Systems SE Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013; Provides Earnings Guidance for the Year 2013 CI
More news
3 months+2.94%
Current year+9.38%
More quotes
1 week
17.50
Extreme 17.5
17.50
1 month
17.50
Extreme 17.5
17.50
Current year
12.00
Extreme 12
17.50
1 year
12.00
Extreme 12
18.70
3 years
12.00
Extreme 12
20.80
5 years
12.00
Extreme 12
23.60
10 years
12.00
Extreme 12
28.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 10-12-31
Members of the board TitleAgeSince
Chief Executive Officer - 10-12-31
Director/Board Member - 22-06-29
Chairman 57 -
More insiders
Date Price Change
24-04-22 17.5 0.00%
24-04-19 17.5 0.00%
24-04-18 17.5 0.00%
24-04-17 17.5 0.00%
24-04-16 17.5 0.00%

End-of-day quote BOERSE MUENCHEN, April 21, 2024

More quotes
Pulsion Medical Systems SE is a Germany-based company that develops and markets minimally invasive physiological monitoring systems for use in intensive care stations and in operating rooms. The Company's products are used primarily to monitor blood circulatory systems in patients. Pulsion also markets disposable measuring catheters and the intravenous diagnostic dye Indocyanine Green. The Company operates worldwide. On February 19, 2014, Getinge AB secured 78.55% of the outstanding shares in Pulsion Medical Systems SE.
More about the company